国際共同研究

We are looking for research teams who wish to collaborate.
Please don't hesitate to contact the Principal Investigator, Prof. Tomotetsu Yoshimura (yoshimurat[at]gifu-pu.ac.jp). [at]=@

国際共同研究 International Collaborative Research

1.医療ビッグデータ解析のための国際ガイドラインの作成
  Developing international guidelines for medical big data analysis

 
 PROJECT: Re
porting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in Pharmacovigilance
READUS-PV Member;野口 義紘 准教授が、Working Comiteeとして参加中)

 

 現在進行中
  Final virtual meeting on July 6th 2023 → First draft of the manuscript planned on September 2023

2.薬剤疫学的手法による医療ビッグデータの解析と臨床への活用
  Analysis of medical big data by pharmacoepidemiologic approach and its practical use


 中南大学 Prof. Miao Yan (csu.edu.cn)
 研究成果

  1. Shuang Xia, Yi-Chang Zhao, Lin Guo, Hui Gong, Yi-Kun Wang, Rui Ma, Bi-Kui Zhang, Yue Sheng, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan, Do antibody-drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study, Front. Pharmacol. 13, 967017. doi: 10.3389/fphar.2022.967017, 2022.
  2. Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan, Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study, Cancers. 15, 240. doi: 10.3390/cancers15010240, 2023.
  3. Shuang Xia, Hui Gong, Yikun Wang, Ling Liu, Yichang Zhao, Lin Guo, ikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan, Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a literature review and database analysis, Front. Pharmacol. 14 1129730. doi: 10.3389/fphar.2023.112973, 2023.
  4. Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Rui Ma, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan, Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database, Clin. Pharmacol. Ther. doi: 10.1002/cpt.2920, 2023.
  5. Shuang Xia, Jia‑ting Ma, Emanuel Raschi, Rui Ma, Bi‑kui Zhang, Linna Guo, Yoshihiro Noguchi, Mayur Sarangdhar, Hui Gong, Miao Yan, Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System, Clin Drug Investig. doi:10.1007/s40261-023-01308-0, 2023.
  6. Shuang Xia, Yunfei Li, Emanuel Raschi, Bi-kui Zhang, Yoshihiro Noguchi, Mayur Sarangdhar, Miao Yan, Jin-an Ma, Pericarditis with biological disease-modifying antirheumatic drugs (bDMARDs) for Ankylosing Spondylitis: a disproportionality analysis in the FAERS database, Front Pharmacol. 15:1275814. doi: 10.3389/fphar.2024.1275814, 2024.

 その他

  1. Yoshihiro Noguchi, Miao Yan, Comment on: "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis", Int. J. Cancer, 153, 238-239. doi: 10.1002/ijc.34498, 2023.
  2. Yoshihiro Noguchi, Miao Yan, Tomoaki Yoshimura, Comment on: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS), Ann. Pharmacother, 2023. doi: 10.1177/10600280231168858.
  3. Yoshihiro Noguchi, Miao Yan, Tomoaki Yoshimura, Questioning Bayesian inference-based models for estimating Culprit Drugs for Adverse Drug Reactions, Clin. Pharmacol. Ther, 2023. doi: 10.1002/cpt.2933.

 広東薬科大学 Prof. Yonggang Shen
 研究成果

  1. Junlin Wu, Hanbiao Wu, Lili Chen, Haiping Liang, Guoning Huang, Sensen Yang, Bishan Chen, Yoshihiro Noguchi, Yonggang Shen, Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database, Expert Opin. Drug Saf. doi: 10.1080/14740338.2023.2296966, 2023.